WebNov 15, 2024 · NervGen Pharma Awarded up to $1.5 Million US Department of Defense Funding to Evaluate NervGen’s NVG-291-R for Peripheral Nerve Injury. View Release. … WebApr 3, 2024 · NervGen Pharma Corp. published this content on 04 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 April 2024 18:36:02 UTC.
NervGen Pharma’s NVG-291-R Demonstrates Significant …
WebNervGen Pharma Corp. 2955 Virtual WaySuite 480Vancouver, BC V5M 4X6 Phone: (778) 731-1711Email: [email protected] Corporate Communications Huitt Tracey(604) 537 … WebVancouver, British Columbia-- (Newsfile Corp. - November 17, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage … ghsa football playoff scores 2020
NervGen Pharma - NGENF Stock Forecast, Price & News
Web6 hours ago · Vancouver - NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) ('NervGen' or the 'Company'), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, will be giving an oral presentation at the upcoming American Spinal Injury Association (ASIA) 50th Annual … WebApril 10, 2024 – NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, today announced the appointment of Mr. Michael Kelly to the position of President & CEO effective April 10, 2024. Mr. WebDec 31, 2024 · NervGen Pharma Corp. announced the appointment of Mr. Michael Kelly to the position of President &CEO effective April 10, 2024. Mr. Kelly has also been appointed as amember of NervGen's Board of Directors. Mr. Kelly currently serves on the Board of Directors of ARS Pharmaceuticals, which he joined in May 2024. ghsa football schedule 2020 2021